Zhangwang Li
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
-
- Ferroptosis and cancer prognosis
Papers in
-
- Inflammasome and immune disorders 5
- Heme Oxygenase-1 and Carbon Monoxide 2
- Glycosylation and Glycoproteins Research 1
-
- Galectins and Cancer Biology 1
- Co-authors
- Panpan Xia (14 shared papers)Ao Shi (5 shared papers)Peng Yu (2 shared papers)Jing Zhang (1 shared paper)Jiahui He (1 shared paper)Xiaoyi Tang (7 shared papers)Peng Yu (7 shared papers)Deju Zhang (5 shared papers)
- Journals
- Cells (2 papers)Molecular Metabolism (2 papers)Frontiers in Immunology (2 papers)Journal of Cellular Physiology (2 papers)Frontiers in Cellular and Infection Microbiology (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Zhangwang Li
20 papers receiving 415 citations
Zhangwang Li's Hit Papers
Peers
Comparison fields: 5 of 79
- Cancer Research 73
- Pulmonary and Respiratory Medicine 111
- Geriatrics and Gerontology 10
- Molecular Medicine 15
- Molecular Biology 170
Countries citing papers authored by Zhangwang Li
This map shows the geographic impact of Zhangwang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhangwang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhangwang Li more than expected).
Fields of papers citing papers by Zhangwang Li
This network shows the impact of papers produced by Zhangwang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhangwang Li. The network helps show where Zhangwang Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhangwang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ferroptosis and ferritinophagy in diabetes complications Hit paper breakdown → | 2022 | 130 |
| 2 | 2022 | 60 | |
| 3 | 2023 | 53 | |
| 4 | 2022 | 25 | |
| 5 | 2022 | 24 | |
| 6 | 2022 | 21 | |
| 7 | 2022 | 21 | |
| 8 | 2022 | 19 | |
| 9 | 2022 | 13 | |
| 10 | 2022 | 11 | |
| 11 | 2022 | 10 | |
| 12 | 2024 | 8 | |
| 13 | 2022 | 6 | |
| 14 | 2022 | 5 | |
| 15 | 2022 | 5 | |
| 16 | 2022 | 2 | |
| 17 | 2023 | 2 | |
| 18 | 2022 | 2 | |
| 19 | 2025 | 2 | |
| 20 | 2009 | 1 |
About Zhangwang Li
Zhangwang Li is a scholar working on Molecular Biology, Immunology, Epidemiology, Cancer Research and Infectious Diseases, having authored 20 papers that have together received 420 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (5 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers), COVID-19 Clinical Research Studies (2 papers), Cancer-related molecular mechanisms research (2 papers), Glycosylation and Glycoproteins Research (1 paper), Ferroptosis and cancer prognosis (1 paper), Galectins and Cancer Biology (1 paper) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Cancer Research (73 citations), Pulmonary and Respiratory Medicine (111 citations), Geriatrics and Gerontology (10 citations), Molecular Medicine (15 citations) and Molecular Biology (170 citations). Zhangwang Li has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Panpan Xia, Ao Shi, Peng Yu, Jing Zhang, Jiahui He, Xiaoyi Tang, Peng Yu, Deju Zhang, Peng Yu and Minxuan Xu. Their work appears in journals such as Cells, Molecular Metabolism, Frontiers in Immunology, Journal of Cellular Physiology and Frontiers in Cellular and Infection Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.